These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10838661

  • 41. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
    Allegrini G, Goulette FA, Darnowski JW, Calabresi P.
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL, Xia Y, Hoshiai K, Tanaka K, Sawamura S, Nakazawa H.
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.
    Biswas SK, Sodhi A, Paul S.
    Nitric Oxide; 2001 Dec; 5(6):566-79. PubMed ID: 11730364
    [Abstract] [Full Text] [Related]

  • 46. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA, Cheshire PJ, Hallman JD, Lutz L, Luo X, Li Y, Houghton PJ.
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T, Kawamura K, von Grafenstein H.
    J Immunol; 1999 Dec 01; 163(11):5770-80. PubMed ID: 10570259
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. PSK and OK-432-induced immunomodulation of inducible nitric oxide (NO) synthase gene expression in mouse peritoneal polymorphonuclear leukocytes and NO-mediated cytotoxicity.
    Asai K, Kato H, Hirose K, Akaogi K, Kimura S, Mukai S, Inoue M, Yamamura Y, Sano H, Sugino S, Yoshikawa T, Kondo M.
    Immunopharmacol Immunotoxicol; 2000 May 01; 22(2):221-35. PubMed ID: 10952028
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress.
    Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K.
    Free Radic Biol Med; 2003 Apr 15; 34(8):1006-16. PubMed ID: 12684085
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene.
    Xie K, Huang S, Dong Z, Juang SH, Wang Y, Fidler IJ.
    J Natl Cancer Inst; 1997 Mar 19; 89(6):421-7. PubMed ID: 9091643
    [Abstract] [Full Text] [Related]

  • 56. Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.
    Ito H, Ando T, Seishima M.
    Oncotarget; 2015 Dec 08; 6(39):41863-74. PubMed ID: 26496031
    [Abstract] [Full Text] [Related]

  • 57. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.
    Xie K, Fidler IJ.
    Cancer Metastasis Rev; 1998 Mar 08; 17(1):55-75. PubMed ID: 9544423
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes.
    Zhang XM, Xu Q.
    Melanoma Res; 2001 Dec 08; 11(6):559-67. PubMed ID: 11725202
    [Abstract] [Full Text] [Related]

  • 60. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages.
    Korhonen R, Lahti A, Hämäläinen M, Kankaanranta H, Moilanen E.
    Mol Pharmacol; 2002 Sep 08; 62(3):698-704. PubMed ID: 12181447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.